| 1 |
M. Uguccioni, M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini, "Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes", Eur. J. Immunol., Vol. 25, pp. 64-68, 1995.
DOI
|
| 2 |
R. W. Chapman, J. E. Phillips, R. W. Hipkin, A. K. Curran, D. Lundell, and J. S. Fine, "CXCR2 antagonists for the treatment of pulmonary disease", Pharmacol. Therapeut., Vol. 12, pp. 55-68, 2009.
|
| 3 |
K. J. Eash, A. M. Greenbaum, P. K. Gopalan, and D. C. Link, "CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow", J. Clin. Invest., Vol. 120, pp. 2423-2431, 2010.
DOI
|
| 4 |
J. Reutershan, A. Basit, E. V. Galkina, and K. Ley, "Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced lung injury", Am. J. Physiol-Lung. C., Vol. 289, pp. L807-L815, 2005.
DOI
|
| 5 |
S. L. Traves, S. J. Smith, P. J. Barnes, and L. E. Donnelly, "Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2", J. Leukocyte Biol., Vol. 76, pp. 441-450, 2004.
DOI
|
| 6 |
R. A. Pauwels and K. F. Rabe, "Burden and clinical features of chronic obstructive pulmonary disease (COPD)", Lancet, Vol. 364, pp. 613-620, 2004.
DOI
|
| 7 |
E. H. Bel, A. Sousa, L. Fleming, A. Bush, K. F. Chung, J. Versnel, A. H. Wagener, S. S. Wagers, P. J. Sterk, and C. H. Compton, "Diagnosis and definition of severe refractory asthma: an international consensus statement from the innovative medicine initiative (IMI)", Thorax, Vol. 66, pp. 910-917, 2010.
|
| 8 |
P. Anderson, "Emerging therapies in cystic fibrosis", Ther. Adv. Respir. Dis., Vol. 4, pp. 177-185, 2010.
DOI
|
| 9 |
P. M. Murphy, "Neutrophil receptors for interleukin-8 and related CXC chemokines", Semin. Hematol., Vol. 34, pp. 311-318, 1997.
|
| 10 |
J. Lesczynski "Challenges and advances in computational chemistry and physics", 2007.
|
| 11 |
B. Sathya and M. Thirumurthy, "Pharmacophore based comparative molecular field analysis of CRTh2 antagonists", J. Chosun Natural Sci., Vol. 8, pp. 89-98, 2015.
DOI
|
| 12 |
B. Sathya and M. Thirumurthy, "Comparative molecular field analysis of caspase-3 inhibitors", J. Chosun Natural Sci., Vol. 7, pp. 166-172, 2014.
DOI
|
| 13 |
M. Thirumurthy, "Modeling aided lead design of FAK inhibitors", J. Chosun Natural Sci., Vol. 4, pp. 266-272, 2011.
|
| 14 |
M. Thirumurthy, "3D-QSAR studies of 3,5-disubstituted quinolines inhibitors of c-jun N-terminal kinase-3", J. Chosun Natural Sci., Vol. 4, pp. 216-221, 2011.
|
| 15 |
D. W. Porter , M. Bradley, Z. Brown, S. J. Charlton, B. Cox, P. Hunt, D. Janus, S. Lewis, P. Oakley, D. O'Connor, J. Reilly, N. Smith, and N. J. Press, "The discovery of potent, orally bioavailable pyrimidine-5- carbonitrile-6-alkyl CXCR2 receptor antagonists", Bioorg. Med. Chem. Lett., Vol. 24, pp. 3285-3290, 2014.
DOI
|
| 16 |
SYBYL Software, Version X 2.0., 2006, Tripos Associates Inc, St. Louis, USA.
|
| 17 |
R. D. Cramer, D. E. Patterson, and J. Bunce, "Comparative molecular field analysis (CoMFA), 1. Effect of shape on binding of steroids to carrier proteins", J. Am. Chem. Soc., Vol. 110, pp. 5959-5967, 1988.
DOI
|
| 18 |
A. M. Doweyko, "3D QSAR illusions", J. Comput. Sci. Tech. Ch., Vol. 18, pp. 587-596, 2004.
|
| 19 |
S. Wold, A. Ruhe, H. Wold, and W. J. Dunn, "The collinearity problem in linear-regression- the partial least squares (PLS) approach to generalized inverses", SIAM Journal on Scientific and Statistical Computing, Vol. 5, pp. 735-743, 1984.
DOI
|
| 20 |
S. Wold, "Cross-validatory estimation of the number of components in factor and principal component model", Technometrics, Vol. 20, pp. 397-405, 1978.
DOI
|
webmaster
